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Studies of genetically engineered flies and mice have revealed the role that orthologs of the human LIM homeobox
LHX4 have in the control of motor-neuron–identity assignment and in pituitary development. Remarkably, these
mouse strains, which bear a targeted modification of Lhx4 in the heterozygous state, are asymptomatic, whereas
homozygous animals die shortly after birth. Nevertheless, we have isolated the human LHX4 gene, as well as the
corresponding cDNA sequence, to test whether it could be involved in developmental defects of the human pituitary
region. LHX4, which encodes a protein 99% identical to its murine counterpart, consists of six coding exons and
spans 145 kb of the q25 region of chromosome 1. We report a family with an LHX4 germline splice-site mutation
that results in a disease phenotype characterized by short stature and by pituitary and hindbrain (i.e., cerebellar)
defects in combination with abnormalities of the sella turcica of the central skull base. This intronic mutation,
which segregates in a dominant and fully penetrant manner over three generations, abolishes normal LHX4 splicing
and activates two exonic cryptic splice sites, thereby predicting two different proteins deleted in their homeodomain
sequence. These findings, which elucidate the molecular basis of a complex Mendelian disorder, reveal the fun-
damental pleiotropic role played by a single factor that tightly coordinates brain development and skull shaping
during head morphogenesis.
Introduction
The pituitary gland, an endocrine gland that occupies
the center of the head, plays vital roles in controlling
functions as various as postnatal growth, reproduction,
and stress response. The mature gland, in humans, is
composed of two lobes: the posterior hypophysis and
the anterior hypophysis. The anterior hypophysis con-
tains a heterogeneous population of highly specialized
cells producing six hormones: growth hormone (GH),
luteinizing hormone (LH), follicle-stimulating hormone
(FSH), thyroid-stimulating hormone (TSH), prolactin
(PRL), and adrenocorticotropin (ACTH) (Ikeda et al.
1988; Japon et al. 1994). The posterior hypophysis orig-
inates from the brain neuroectoderm, whereas the an-
terior hypophysis originates from Rathke’s pouch, an
invagination of the oral ectoderm that derives from the
most anterior part of the neural ridge. At the end of
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embryonic development, the two lobes of the pituitary
gland are grouped together within the sella turcica, a
depression of the upper surface of the central body of
the sphenoid bone (Couly and Le Douarin 1988; Ea-
gleson and Harris 1990; Osumi-Yamashita et al. 1994;
Dubois et al. 1997). Although the factors that regulate
the coordinated formation of the pituitary gland and
surrounding structures are still unknown, one might
suggest that the proper development of this region
could be affected by alterations in the recently iden-
tified pituitary-specific transcriptional cascades (Wat-
kins-Chow and Camper 1998).
Several developmental defects of the pituitary region
have indeed been reported in humans. These disorders
are characterized by an extreme variability in expression
of the disease phenotype. Patients present with clinical
features revealing a deficit of one or several pituitary
hormones, the latter condition being referred to as “com-
bined pituitary-hormone deficiency.” These conditions,
which are clinically and genetically heterogeneous, have
been linked with rare abnormalities of genes encoding
transcription factors necessary for pituitary development
(Pfaffle et al. 1992; Radovick et al. 1992; Tatsumi et al.
1992; Dattani et al. 1998; Wu et al. 1998; Netchine et
al. 2000; Lamolet et al. 2001). One of these genes, which
has been identified in mice, is Lhx4 (MIM 602146)—a
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LIM-homeobox gene—which has been shown to regu-
late, together with the closely related Lhx3, proliferation
and differentiation of pituitary lineages (Sheng et al.
1997). Although genetically engineered mice bearing a
targeted modification of Lhx4 in the heterozygous state
are asymptomatic—and although homozygous animals,
which have an abnormal pituitary phenotype, die shortly
after birth—we sought out the human ortholog of this
gene and evaluated its role in the pathogenesis of devel-
opmental defects of the pituitary region.
Patients and Methods
Patients
The probands presented at Robert Debre´ Hospital in
Paris, with combined deficiency of three anterior pitui-
tary hormones (i.e., GH, TSH, and ACTH). Levels of
gonadotrophins (i.e., LH and FSH) were not investigated
because of the early age of the probands. Radiographs
and magnetic-resonance imaging of the head showed a
small sella turcica, a persistent craniopharyngeal canal,
a hypoplastic anterior hypophysis associated with a de-
formation, into a pointed configuration, of the cerebellar
tonsils, and an ectopic posterior hypophysis; the pos-
terior hypophysis was detected as a bright spot near the
optic chiasma, in patient IV1, and in the middle of the
pituitary stalk, in patient IV3 (see below). The probands’
mother (III3) is 148 cm tall. She has a small sella turcica
and a hypoplastic anterior hypophysis associated with
a deformation, into a pointed configuration, of the cer-
ebellar tonsils; the posterior hypophysis is at its normal
anatomical position. III3 has two sisters, who are 160
cm and 140 cm tall. The probands’ maternal grandfather
(II2) is 150 cm tall and has a small sella turcica. The
probands’ maternal great-grandmother is 140 cm tall.
Cloning and Sequencing of the Human LHX4 cDNA
and Genomic DNA
To isolate the human ortholog of Lhx4, we searched
for homology between the Lhx4 cDNA sequence and the
sequences in the human expressed-sequence tag (EST) da-
tabase, by use of BLAST. These alignments indicated the
existence of two human ESTs that may correspond to the
human LHX4 transcript. In silico mapping of these ESTs
in GeneMap’99 led to the identification of a YAC (802b5;
Centre d’E´tude du Polymorphisme Humain) containing
LHX4. On the basis of both the mouse Lhx4 cDNA
sequence (GenBank accession number AF135415) and the
human EST sequences, we designed exonic primers that
permitted us to amplify a fragment spanning exons 4–6
of the human LHX4 gene. Thereafter, by combining in
silico (BLAST) and in vitro methods, we designed sense
and antisense intronic and exonic primers that permitted
us to amplify exons 1–3. We isolated the human LHX4
cDNA by reverse-transcriptase PCR (RT-PCR) amplifi-
cations performed with adult-human pituitary poly(A)
RNA (Clontech) as a template, by use of two seminested
couples of exonic primers designed on the basis of the
human LHX4 sequence. All sequences were determined,
for both strands.
Mapping of Human LHX4
The chromosomal localization of human LHX4 was
determined by FISH of human-chromosome spreads
with the biotin-labeled YAC clone 802b5.
Mutation Analysis
For each individual, we isolated genomic DNA from
peripheral-blood samples, according to standard tech-
niques. First, we tested the implication of theLHX3 gene
in the disease phenotype of patient IV1, by LHX3-spe-
cific primers (Netchine et al. 2000); all LHX3 exons and
intronic boundaries displayed a normal sequence (data
not shown). Then, we amplified the LHX4 coding exons
(exons 1–3 and a fragment spanning exons 4–6) and
their flanking intronic sequences, by intronic and exonic
primers, and sequenced the corresponding PCR prod-
ucts, on both strands.
Constructions
A human LHX4 cDNA fragment spanning exons 1–4
was fused to a genomic fragment spanning exons 4–6
and originating from the normalLHX4 allele. This mini-
gene was cloned into the pTracer-CMV expression vec-
tor (Invitrogen), according to standard procedures, by
use of T4 DNA Ligase (Biolabs). This product was sub-
sequently subjected to site-directed mutagenesis by the
QuickChange kit (Stratagene), with oligonucleotides de-
signed to introduce the GrC substitution that was found
in the patients.
Transfections
Chinese hamster ovary (CHO) cells were obtained from
the American Type Culture Collection and were grown
in Iscove medium (Life Technologies) containing 10% fe-
tal-calf serum (Life Technologies). Transfections were per-
formed using the Lipofectamine-Plus method (Life Tech-
nologies) in OptiMEM medium, according to the
manufacturer’s standard protocol. Approximately 48 h
after transfection of either the wild-type or the mutant
minigenes, total RNA was isolated. RT-PCR was per-
formed using several sets of primers located on theLHX4
coding sequence, a procedure allowing us to study the
effect that the mutation identified in the patients had on
the processing of LHX4 primary transcripts.
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Figure 1 Genomic structure, chromosomal localization, and predicted amino acid sequence of human LHX4. A, Intron-exon organ-
ization of human LHX4. The six exons (E1–E6) encoding LHX4 are indicated by boxes with either solid or dashed borders, depicting
translated or untranslated sequences, respectively. Sequences encoding the two LIM domains and the homeodomain are shaded dark gray
and light gray, respectively. The locations of the ATG initiation codon and of the TAA stop codon are shown. The number of the first codon
in each exon is indicated; exons beginning with the first, second, or third base of a codon are indicated by the subscripts “1,” “2,” or “3,”
respectively. Exons are drawn to scale. B, Chromosomal mapping of human LHX4 by FISH. The fine localization of LHX4 to 1q25 is
indicated by the black arrow (right). An ideogram of chromosome 1 is given (left). C, Comparison of deduced amino acid sequences of
human and mouse LHX4. Different residues are indicated by an asterisk. The two LIM domains and the homeodomain are shaded dark
gray and light gray, respectively.
Results
Cloning and Mapping of LHX4
We isolated the human ortholog of mouse Lhx4 by
combining in silico and in vitro methods. The human
gene, which spans 145 kb, is composed of six translated
exons, as deduced by the alignment of the genomicLHX4
sequence and the corresponding cDNA sequence, the lat-
ter of which was obtained using human-pituitary cDNA
as a template. Sequences from exons 2 and 3 encode the
first and second LIM domains, respectively, whereas se-
quences from exons 4 and 5 encode the homeodomain
(fig. 1A). The human gene is located on the long arm of
chromosome 1 (fig. 1B), in a region (q25) syntenic to the
mouse chromosome 1 region that was shown to contain
Lhx4 (Yamashita et al. 1997). Comparison of murine and
human LHX4 amino acid sequences, as deduced from
their cDNA sequences, showed that LHX4 has been ex-
tremely conserved (i.e., 99% identical) between these two
species (fig. 1C)—a result demonstrating that this se-
quence is indeed the human ortholog of mouse Lhx4.
Identification of an LHX4 Splice Mutation
The phenotypic abnormalities of the probands (patients
IV1 and IV3, as shown in the pedigree presented in fig.
2A; also see table 1) included short stature due to GH
deficiency (as well as deficits of other anterior pituitary
hormones associated with a hypoplastic anterior hypo-
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Figure 2 Pedigree and phenotypic features of kindred presenting
with brain and skull developmental abnormalities. A, Pedigree of family.
Black symbols denote affected individuals, gray symbols denote individ-
uals with uncertain phenotypic status, and white symbols denote un-
affected individuals; circles denote females, and squares denote males;
a slash through a symbol denotes a deceased individual. Although in-
dividuals I1 and III2 exhibit short stature—as in the patients’ pheno-
type—their phenotypic status remains uncertain, because no further clin-
ical and biological information was available. Heights (in cm) are
indicated under the corresponding symbols. Probands are indicated by
arrows.B,Radiographs of sella turcica region. The shapes of sella turcica
from a normal individual (left) and from patient IV3 (right) are high-
lighted by black Xs.
Table 1
Phenotypic Features of the Two Probands
Patient
Peak GHa
(mg/liter)
Free
Thyroxineb
(pmol/liter)
Basal PRLc
(mg/liter)
Basal
Cortisold
(mg/liter)
IV1 .8 3.7 8 80
IV3 3.3 9.8 5 50
NOTE.—Both probands have a hypoplastic anterior hypophysis, an
ectopic posterior hypophysis, a poorly developed sella turcica, and de-
formation of the cerebellar tonsils.
a After arginine-insulin stimulation (normal value 110 mg/liter).
b Normal value is 110 pmol/liter.
c Normal baseline range is 3–15 mg/liter.
d Normal value is 1100 mg/liter.
physis), poorly developed sella turcica (fig. 2B), and de-
formation, into a pointed configuration, of the cerebellar
tonsils (which is characteristic of the tonsillar herniation,
outside the skull, that defines the Chiari malformation
[MIM 118420]). DNA samples from six members of this
family were screened for mutations within the LHX4
gene. This study revealed that patients II2, III3, IV1, and
IV3 displayed a heterozygous intronic point mutation
(GrC transversion) involving the invariant dinucleotide
(AG) of the splice-acceptor site preceding exon 5, whereas
individuals III4 and IV2, who both exhibited a normal
phenotype, bore the intact AG sequence. This nucleotide
substitution results in the creation of a recognition site
forMaeII, thereby allowing the distinction, by RFLP anal-
ysis, between normal and mutant alleles (fig. 3A and B).
One Mutant LHX4 Allele Predicting Two Mutant LHX4
Proteins
To determine the consequences that this splice-acceptor-
site mutation has on the processing of pituitary LHX4
transcripts, CHO cells were transfected with normal or
mutant LHX4 allelic constructs. Because of the large size
of the gene, a human LHX4 cDNA fragment spanning
exons 1–4 was fused to a genomic fragment spanning
exons 4–6 and corresponding to either the normal allele
or the mutant allele. RT-PCR amplification ofLHX4 tran-
scripts isolated from cells transfected with the wild-type
minigene yielded a 1,264-bp amplicon consistent with the
normal splicing of the intron located between exons 4
and 5. In contrast, a similar assay, performed using the
mutant construct, generated two fragments, of 1,252 bp
and 1,247 bp (17 and 3 clones, respectively, of the 20
clones tested). Sequence analysis of these latter products
revealed that they resulted from the use of two cryptic
splice-acceptor sites located within exon 5 (fig. 4A); at
the protein level, the use of the first splice-acceptor site
would lead to the in-frame deletion of four highly con-
served amino acids in the third helix (i.e., helix III/IV) of
the homeodomain (i.e., deletion of VWFQ at positions
47–50 in the homeodomain); the use of the second splice-
acceptor site would alter the reading frame at position 47
of the homeodomain, leading to a premature termination
codon within exon 5 (fig. 4B). The nature and the location
of this mutation therefore are consistent with a drastic
alteration of the function of LHX4.
Discussion
We have described the molecular basis of a complex
Mendelian disorder characterized by short stature and
pituitary and cerebellar defects in combination with ab-
normalities of the central skull base. We have shown
that this condition is due to a germline mutation within
the LIM-homeobox transcription factor LHX4, a result
revealing previously unsuspected functions of this gene.
In this study, we have provided evidence that a GrC
substitution in the intron preceding exon 5 of LHX4 is
indeed the defect responsible for autosomal dominant
syndromic short stature, on the basis of the following
data: (a) Within this large family, over three generations,
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Figure 3 Identification of LHX4 molecular defect. A, Nucleotide
sequences of normal (top) and mutant (bottom) LHX4 alleles, as de-
termined after cloning of the LHX4 PCR products into TOPO-XL clon-
ing vectors (Invitrogen). The GrC substitution (boldface; position in-
dicated by asterisk) identified in the mutant allele creates a recognition
sequence for the MaeII restriction enzyme (box). B, Segregation analysis
of splice-acceptor–site mutation in the family. The presence of the mu-
tation in the genomic DNA of six family members was assessed by means
of MaeII digestion of PCR products generated by primers bracketing the
splice site. This assay confirmed that all affected members tested (lanes
II2, III3, IV1, and IV3) have one mutant (244 bp and 108 bp) and one
normal (352 bp) allele, whereas the unaffected individuals (III4 and IV2)
have only normal (352 bp) alleles. The size marker (lane L) is the “Smart-
ladder” (Eurogentec).
there is a perfect cosegregation of this mutation with
the disease phenotype. (b) This mutation involves the
last invariant nucleotide of a splice-acceptor site, the
functional importance of which, in the proper splicing
of primary transcripts, is well documented (Shapiro and
Senapathy 1987; Burset et al. 2001). (c) As shown by
means of in vitro–expression studies, this mutation
abolishes normal LHX4 splicing and activates two cryp-
tic splice-acceptor sites located within exon 5. (d) If
translated, the two aforementioned abnormal tran-
scripts would generate LHX4 proteins with mutations
in their helix III/IV of the homeodomain—one tran-
script would generate an in-frame deletion of four
highly conserved residues of the 60-amino-acid-long ho-
meodomain, and the other would generate a truncated
protein in which the homeodomain is severely affected;
helix III/IV is the region of the homeodomain-contain-
ing transcription factors that is in contact with the major
groove of the DNA (Gehring et al. 1994). This helix
therefore is essential for the formation of homeodo-
main-specific DNA-target complexes. Altogether, these
data strongly suggest that the LHX4 intronic variation
identified herein is the disease-causing mutation, which
most probably results in the inability of LHX4 to con-
trol the expression of as-yet-unknown target genes.
Remarkably, in mice, the targeted disruption of Lhx4
is asymptomatic in the heterozygous state. In contrast,
the LHX4 mutation identified in this kindred is re-
sponsible for a complex disease phenotype in the het-
erozygous state, thereby raising the question of what
the mechanism is by which such a defect impairs LHX4-
dependent transcriptional cascades. Also, we cannot ex-
clude the possibility that this mutation may be lethal in
the homozygous state, since that is the case in animals
carrying the Lhx4/ genotype (Li et al. 1994; Sheng et
al. 1997).
It may seem somewhat surprising that the probands,
who were born of a consanguineous union, carry the
defect at the LHX4 locus in the heterozygous state; how-
ever, several lines of evidence indicate that consanguinity
is irrelevant to the occurrence of the disease condition.
First, the pathological trait is transmitted in a dominant
manner, affecting only the maternal side of the kindred.
Second, the mutant allele cosegregates perfectly, over at
least three generations, with the complex disease phe-
notype (i.e., all individuals who bear one copy of the
mutant allele exhibit short stature and the defect in the
sella turcica). In addition, variability in clinical expression
of the disease phenotype—which segregates in a fully
penetrant manner—has been clearly documented in this
kindred. This phenomenon, which is a common feature
of dominantly inherited genetic disorders, may reflect the
existence of epigenetic events and/or modifying factors
(Peltonen and McKusick 2001). In the family presented
herein, such variability in clinical expression of the dis-
ease phenotype is indeed observed in more than one
aspect of the phenotype—although the probands have
a deficit of several anterior pituitary hormones, the
other patients present with an isolated GH deficiency
revealed by short stature. In addition, the two probands
display an ectopia of the posterior hypophysis, but this
phenotypic feature—the expression of which varies be-
tween these two patients—is not observed in all affected
individuals.
Finally, the disease phenotype includes the pointed cer-
ebellar tonsils observed in patients with Chiari malfor-
mation (Meadows et al. 2000), a heterogeneous condi-
tion of unknown etiology. We therefore assume that
LHX4-dependent transcriptional cascades could be im-
plicated in the pathogenesis of a developmental anomaly
that, together with the abnormal location of the posterior
hypophysis, somehow is reminiscent of the cell-pathfind-
ing defect in Lhx4/ mice described elsewhere (Sharma
et al. 1998). It is also worth noting that, in addition to
Figure 4 Consequences of LHX4 intronic mutation, at RNA level and protein level. A, Effect that mutation has on splicing of LHX4 primary
transcripts. Top, Sequence electropherograms of normal and mutant LHX4 transcripts. The mutant allele generates two populations of
transcripts—one with a deletion of 12 nucleotides (LHX4_mut1) and another with a deletion of 17 nucleotides (LHX4_mut2), both located within
the coding sequence of exon 5. Bottom, Schematic representation of in vitro splicing of normal and mutant LHX4. The location of the GrC
substitution is indicated by an asterisk. The invariant splice-donor site and the three splice-acceptor sites (i.e., the site normally used, as well as the
two cryptic splice sites that are activated in the mutated allele) are underlined. B, Evolutionary conservation of amino acid residues involved in
LHX4-homeodomain deletions generated by mutant allele. Top, Schematic presentation of genomic structure of LHX4. Exons are drawn to scale
and are depicted by rectangles. (Introns are not drawn to scale.) Sequences from exons 4 and 5 encode the homeodomain (shaded). The splice-
acceptor–site mutation (indicated by an asterisk) is located upstream from exon 5. Bottom, Normal and mutant LHX4-homeodomain amino acid
sequences. The amino acid sequence of normal LHX4 (LHX4_wt) is shown against a light-gray background. Helices are denoted by black boxes.
In the consensus sequence, the seven positions occupied by amino acids that are invariant in 195% of the homeodomain proteins thus far identified
are indicated by red letters. Highly conserved residues (i.e., at the most, three different amino acids at these locations in all homeodomain proteins
thus far identified) are indicated by green letters (Burglin, T. R.). The mutant allele generates two populations of transcripts (encoding mutant LHX4
proteins)—one maintaining the normal reading frame and another changing the reading frame and resulting in the creation of a premature termination
codon within exon 5. The four amino acids, which are deleted when either of the two cryptic splice-acceptor sites is used, are indicated on the
normal LHX4-homeodomain sequence (del). The LHX4-homeodomain products (LHX4_mut1 and LHX4_mut2) resulting from the mutation are
drawn to scale, in proportion to the length of the normal homeodomain. Part of the nonsense sequence, which results from the frameshift introduced
by the activation of the splice-acceptor site located 17 nucleotides downstream of the normal one, is shown in italic against a dark-gray background.
Numbers indicate the total length of predicted amino acid sequences.
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the pituitary and hindbrain defects, the patients display
a poorly developed sella turcica; this strongly suggests
that an LHX4-induced signaling pathway therefore is
required for proper shaping of the sphenoid bone un-
derneath the pituitary gland. Overall, these data, which
elucidate the molecular basis of a complex developmen-
tal disorder, reveal unsuspected functions of LHX4, a
homeodomain transcription factor that hence emerges as
a morphogenetic organizer of cephalic development in
humans.
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